Phase IB/II study to evaluate safety and preliminary efficacy of the WEE1 inhibitor Debio 0123 in combination with sacituzumab govitecan (SG) in triple-negative or hormone receptor–positive (HR+)/HER2 ...
(MENAFN- EIN Presswire) EINPresswire/ -- CP Group (CPG), a leading designer, manufacturer, and integrator of advanced material recovery facilities (MRFs) and automated sorting technologies, today ...
Excire Search 2026 is a Lightroom Classic plugin developed by the German company Excire. It uses local artificial ...
Flow core facilities are under growing pressure to support fragile cells, rare populations, and advanced applications such as single-cell multiomics and cell therapy workflows, all while meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results